TuHURA Biosciences Statistics
Total Valuation
HURA has a market cap or net worth of $158.03 million. The enterprise value is $163.05 million.
Important Dates
The last earnings date was Thursday, November 14, 2024, after market close.
Earnings Date | Nov 14, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
HURA has 42.03 million shares outstanding.
Current Share Class | 42.03M |
Shares Outstanding | 42.03M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | n/a |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.92
Current Ratio | 4.92 |
Quick Ratio | 3.68 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | -4.02 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | n/a |
Profits Per Employee | -$19.33M |
Employee Count | 1 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -68.40% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -68.40% |
50-Day Moving Average | 5.72 |
200-Day Moving Average | 6.01 |
Relative Strength Index (RSI) | 38.31 |
Average Volume (20 Days) | 74,592 |
Short Selling Information
The latest short interest is 83,680, so 0.20% of the outstanding shares have been sold short.
Short Interest | 83,680 |
Short Previous Month | 3.18M |
Short % of Shares Out | 0.20% |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -14.61M |
Pretax Income | n/a |
Net Income | -19.33M |
EBITDA | -14.48M |
EBIT | -14.61M |
Earnings Per Share (EPS) | -$0.25 |
Full Income Statement Balance Sheet
The company has $19.60 million in cash and $24.61 million in debt, giving a net cash position of -$5.01 million or -$0.12 per share.
Cash & Cash Equivalents | 19.60M |
Total Debt | 24.61M |
Net Cash | -5.01M |
Net Cash Per Share | -$0.12 |
Equity (Book Value) | -2.77M |
Book Value Per Share | -0.04 |
Working Capital | 21.29M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$15.16 million and capital expenditures -$76,153, giving a free cash flow of -$13.25 million.
Operating Cash Flow | -15.16M |
Capital Expenditures | -76,153 |
Free Cash Flow | -13.25M |
FCF Per Share | -$0.32 |
Full Cash Flow Statement Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |